| Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ... The Lancet Neurology 19 (5), 422-433, 2020 | 815 | 2020 |
| Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology NJ Ashton, TA Pascoal, TK Karikari, AL Benedet, J Lantero-Rodriguez, ... Acta neuropathologica 141, 709-724, 2021 | 368 | 2021 |
| Enrichment of glycopeptides for glycan structure and attachment site identification J Nilsson, U Rüetschi, A Halim, C Hesse, E Carlsohn, G Brinkmalm, ... Nature methods 6 (11), 809-811, 2009 | 361 | 2009 |
| Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease E Portelius, N Bogdanovic, MK Gustavsson, I Volkmann, G Brinkmalm, ... Acta neuropathologica 120, 185-193, 2010 | 358 | 2010 |
| Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease H Kvartsberg, FH Duits, M Ingelsson, N Andreasen, A Öhrfelt, ... Alzheimer's & Dementia 11 (10), 1180-1190, 2015 | 327 | 2015 |
| SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease A Brinkmalm, G Brinkmalm, WG Honer, L Frölich, L Hausner, L Minthon, ... Molecular neurodegeneration 9, 1-13, 2014 | 282 | 2014 |
| Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid A Halim, G Brinkmalm, U Rüetschi, A Westman-Brinkmalm, E Portelius, ... Proceedings of the National Academy of Sciences 108 (29), 11848-11853, 2011 | 244 | 2011 |
| A novel pathway for amyloid precursor protein processing E Portelius, E Price, G Brinkmalm, M Stiteler, M Olsson, R Persson, ... Neurobiology of aging 32 (6), 1090-1098, 2011 | 198 | 2011 |
| Characterization of amyloid β peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry E Portelius, AJ Tran, U Andreasson, R Persson, G Brinkmalm, ... Journal of proteome research 6 (11), 4433-4439, 2007 | 179 | 2007 |
| An Alzheimer's disease-specific β-amyloid fragment signature in cerebrospinal fluid E Portelius, H Zetterberg, U Andreasson, G Brinkmalm, N Andreasen, ... Neuroscience letters 409 (3), 215-219, 2006 | 160 | 2006 |
| The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease A Öhrfelt, A Brinkmalm, J Dumurgier, G Brinkmalm, O Hansson, ... Alzheimer's research & therapy 8, 1-10, 2016 | 153 | 2016 |
| Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease C Cicognola, G Brinkmalm, J Wahlgren, E Portelius, J Gobom, NC Cullen, ... Acta neuropathologica 137, 279-296, 2019 | 145 | 2019 |
| Assignment of saccharide identities through analysis of oxonium ion fragmentation profiles in LC–MS/MS of glycopeptides A Halim, U Westerlind, C Pett, M Schorlemer, U Ruetschi, G Brinkmalm, ... Journal of proteome research 13 (12), 6024-6032, 2014 | 135 | 2014 |
| Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls H Kvartsberg, E Portelius, U Andreasson, G Brinkmalm, K Hellwig, ... Alzheimer's research & therapy 7, 1-9, 2015 | 130 | 2015 |
| Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility TK Karikari, NJ Ashton, G Brinkmalm, WS Brum, AL Benedet, ... Nature Reviews Neurology 18 (7), 400-418, 2022 | 126 | 2022 |
| Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease FH Duits, G Brinkmalm, CE Teunissen, A Brinkmalm, P Scheltens, ... Alzheimer's research & therapy 10, 1-9, 2018 | 116 | 2018 |
| Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method A Öhrfelt, H Zetterberg, K Andersson, R Persson, D Secic, G Brinkmalm, ... Neurochemical research 36, 2029-2042, 2011 | 115 | 2011 |
| A parallel reaction monitoring mass spectrometric method for analysis of potential CSF biomarkers for Alzheimer's disease G Brinkmalm, S Sjödin, AH Simonsen, SG Hasselbalch, H Zetterberg, ... PROTEOMICS–Clinical Applications 12 (1), 1700131, 2018 | 113 | 2018 |
| Enzymatic degradation of carboxymethyl cellulose hydrolyzed by the endoglucanases Cel5A, Cel7B, and Cel45A from Humicola insolens and Cel7B, Cel12A and Cel45Acore … J Karlsson, D Momcilovic, B Wittgren, M Schülein, F Tjerneld, ... Biopolymers: Original Research on Biomolecules 63 (1), 32-40, 2002 | 111 | 2002 |
| Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis TK Karikari, A Emeršič, A Vrillon, J Lantero‐Rodriguez, NJ Ashton, ... Alzheimer's & Dementia 17 (5), 755-767, 2021 | 93 | 2021 |
